RHUMBLINE ADVISERS - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,684,034
+46.7%
73,459
+5.5%
0.00%
+100.0%
Q2 2023$1,147,671
+74.9%
69,598
+22.2%
0.00%0.0%
Q1 2022$656,000
+8.6%
56,942
-5.9%
0.00%0.0%
Q4 2021$604,000
-24.5%
60,537
-1.2%
0.00%0.0%
Q3 2021$800,000
-33.1%
61,287
+0.5%
0.00%
-50.0%
Q2 2021$1,195,000
+39.9%
61,012
+51.9%
0.00%
+100.0%
Q1 2021$854,000
-30.9%
40,155
-3.4%
0.00%
-50.0%
Q4 2020$1,236,000
+47.3%
41,578
+7.4%
0.00%
+100.0%
Q3 2020$839,000
-15.7%
38,713
-13.3%
0.00%
-50.0%
Q2 2020$995,000
+89.5%
44,628
+29.3%
0.00%
+100.0%
Q1 2020$525,000
-29.4%
34,504
+6.5%
0.00%0.0%
Q4 2019$744,000
+33.3%
32,395
+25.3%
0.00%0.0%
Q3 2019$558,000
-2.8%
25,853
-0.9%
0.00%0.0%
Q2 2019$574,000
+6.9%
26,093
+33.1%
0.00%0.0%
Q1 2019$537,000
+2.1%
19,603
+0.3%
0.00%0.0%
Q4 2018$526,000
+49.0%
19,553
+61.7%
0.00%0.0%
Q3 2018$353,000
-1.1%
12,095
+5.8%
0.00%0.0%
Q2 2018$357,00011,4340.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders